Men In AndroGel Lawsuits and Testosterone Treatment Lawsuits Contend The Use Of Low-T Drugs, Such As AndroGel, Axiron, And Androderm, Cause Heart Attacks, Strokes, Blood Clots And Cardiac Death.
As bellwether trial preparations are underway in the U.S. District Court, Northern District of Illinois for low testosterone lawsuits involving the AndroGel testosterone drug, AbbVie, the maker of AndroGel, proposed that the court, rather than plaintiffs’ and defendants’ attorneys, select 32 potential AndroGel lawsuits for trial, according to court records. At a status conference on August 14, plaintiffs’ attorneys disagreed with AbbVie’s recommendation and proposed following the court’s order of having each side select 16 potential AndroGel bellwether cases. U.S District Judge Matthew Kennelly, who is managing the federal testosterone litigation, met with attorneys on August 18 regarding their differences with the AndroGel bellwether case selection process, according to the court docket. Judge Kennelly has taken the matter under advisement and proposed an alternative to the parties’ proposals which he directed the attorneys to discuss, the docket entry stated. More than 2,300 testosterone treatment lawsuits are pending in the Northern Illinois district court, with the majority of the Low Testosterone Drug lawsuits filed against AbbVie. The Low-T drug complaints allege that testosterone products have caused heart attack, stroke, blood clots, and cardiac death in men who have used the medication. The vast majority of the testosterone treatment lawsuits are filed against AbbVie. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)
“Bellwether trials are essential to this testosterone multidistrict litigation (MDL) because the cases selected for trial are representative of the other lawsuits pending in the MDL and the verdicts will predict the outcome of the cases scheduled for trial in the future.” – Southern Med Law.
Southern Med Law aggressively and effectively advocates and represents for people who have been injured due to dangerous and defective drugs. If you or someone you love have been harmed by prescription testosterone drugs, please call Southern Med Law to learn more about your legal rights today. Call the office directly at 205-547-5525 for a free, no obligation testosterone therapy lawsuit review or by filling out our online form on www.southernmedlaw.com.
Court documents state that low testosterone products are used to treat hypogonadism in men with low levels of testosterone due to a medical condition and not due to the aging process. Testosterone therapy lawsuits began to mount after the U.S. Food and Drug Administration (FDA) began in January 2014 to re-evaluate the safety and effectiveness of testosterone gels, creams, patches and injections. The federal regulatory agency said its review was prompted by adverse event reports and studies suggesting that testosterone drugs caused heart attack, stroke, blood clots and cardiac death among men who use the medication. After evaluating testosterone products for over a year, the FDA announced in March 2015 that testosterone manufacturers would be required to update their product labels to warn of the possible increase risk of heart attack or stroke in patients using testosterone products. The agency also required testosterone manufacturers to conduct a “well-designed clinical trial to more clearly address the question of whether an increased risk of heart attack or stroke exists among users of these products.”
[fda.gov/Drugs/DrugSafety/ucm436259.htm, March 3, 2015]
As stated in court documents, a MDL was established in the U.S. District Court, Northern District of Illinois in June 2014 for testosterone lawsuits filed against six makers of testosterone products. The majority of testosterone complaints are filed against the popular AndroGel drug maker and marketer, AbbVie and Abbot Laboratories. Judge Kennelly ordered attorneys for both sides to select AndroGel cases in two categories: thromboembolism clotting injury cases (deep vein thrombosis, pulmonary embolism or other clotting cases) and cardiovascular cases (heart attack). Judge Kennelly scheduled bellwether trials for the AndroGel bellwether cases to begin between October 2016 and April 2017. (In re: Testosterone Replacement Therapy Product Liability Litigation – MDL No. 2545)
About Southern Med Law And Filing A Testosterone Treatment Lawsuit
Throughout his career, Dr. François Blaudeau, founder of Southern Med Law, has worked hard to develop a strong reputation in healthcare litigation through Southern Med Law. Dr. Blaudeau’s first-hand knowledge of medicine has made Southern Med Law an aggressive and effective legal advocate for those who were harmed due to dangerous and defective drugs. If you believe that you or a loved one was injured by testosterone products, please contact Southern Med Law today to learn more about your legal rights. You can arrange for a free, no obligation testosterone therapy lawsuit review by filling out our online form, or by calling the office directly at 205-547-5525.
Southern Med Law
Southern Institute for Medical and Legal Affairs
2224 1st Ave., North
Birmingham, AL 35203
Phone: (205) 547-5525